Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // February 17th, 2010 // 7:51 am
Top of the morning to you and nice to see you again. The sun is shining here on the Pharmalot corporate campus, where the short people are fast asleep, enjoying a week-long respite from the demands of the local schoolhouse. We, however, are fully immersed in our usual routine and, so, have rummaged around to find a few interesting items to help you motor through the day. Have a good one…
Cholesterol Drugs Raise Diabetes Risk By 9% (Bloomberg News)
Novartis VC Arms Backs Universal Flu Firm (Reuters)
Arkansas To Get $18.5M In Lilly Zyprexa Settlement (Associated Press)
Teva & Actavis May Be Final Ratiopharm Bidders (Bloomberg News)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Actavis, Arkansas, AstraZeneca, Cholesterol, Diabetes, Novartis, Ratiopharm, Statins, Teva Pharmaceuticals, Zyprexa